Chiara Monge

Via Pietro Giuria 9
Turin, 10125, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Erratum to "Gemcitabine-loaded ICOS-Fc decorated nanosponges: a new chemo immunotherapy combination against pancreatic cancer". [Int. J. Pharm. 682 (2025) 125869].

Erratum to "Gemcitabine-loaded ICOS-Fc decorated nanosponges: a new chemo immunotherapy combination against pancreatic cancer". [Int. J. Pharm. 682 (2025) 125869].

Journal: International journal of pharmaceutics

Published: January 15, 2026

Gemcitabine-loaded ICOS-Fc decorated nanosponges: A new chemo immunotherapy combination against pancreatic cancer.

Gemcitabine-loaded ICOS-Fc decorated nanosponges: A new chemo immunotherapy combination against pancreatic cancer.

Journal: International journal of pharmaceutics

Published: February 20, 2025

Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases.

Green Solid Lipid Nanoparticles by Fatty Acid Coacervation: An Innovative Nasal Delivery Tool for Drugs Targeting Cerebrovascular and Neurological Diseases.

Journal: Pharmaceutics

Published: July 02, 2024

Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma.

Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma.

Journal: Bioorganic chemistry

Published: December 06, 2023

Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas.

Cell Membrane Fragment-Wrapped Parenteral Nanoemulsions: A New Drug Delivery Tool to Target Gliomas.

Journal: Cells

Published: November 27, 2023

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma.

Nrf2 as a Therapeutic Target in the Resistance to Targeted Therapies in Melanoma.

Journal: Antioxidants (Basel, Switzerland)

Published: May 25, 2023

Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications.

Exploiting Nanomedicine for Cancer Polychemotherapy: Recent Advances and Clinical Applications.

Journal: Pharmaceutics

Published: January 20, 2023

Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle.

Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle.

Journal: Antioxidants (Basel, Switzerland)

Published: December 29, 2022

Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering.

Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering.

Journal: International journal of molecular sciences

Published: December 09, 2022

Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment.

Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment.

Journal: Nanomaterials (Basel, Switzerland)

Published: October 20, 2022

ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.

ICOS-Fc as innovative immunomodulatory approach to counteract inflammation and organ injury in sepsis.

Journal: Frontiers in immunology

Published: July 12, 2022

ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo.

ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo.

Journal: International journal of molecular sciences

Published: June 01, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026